NCT01561924
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Berkeley, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States